SpletPred 1 dnevom · Apr 13, 2024. Amazon.com Inc. (NASDAQ: AMZN) is seeking its first HQ2-related incentive payment from Virginia, asking the commonwealth for nearly $153 … SpletISSN: 2164-6570 (Print) , 2164-6589 (Online) Editor: Tom S. Clark Emory University, USA. Editorial board. JLC will be published by the Cambridge University Press in association …
Followers Ello
Splet03. jun. 2024 · IF2024 - The latest Journal Impact Factors [Jun 2024] View. Assignment of an impact factor to our journal. Article. Apr 2010; Yasutomo Fujii; View. Impact factor of this year. (Latest) Data. SpletPassionate microbiologist specialised in mycology with objective to succeed as Subject Matter Expert. Always keeping abreast with the latest journal and review papers in the field related to microbiology. Authored two publications (as listed). My greatest achievement was when my publications were cited by fellow researchers. I aim … patricia reuter lorenz
Law Journals Oxford Academic
SpletPred 1 dnevom · First Look: Henry Big Boy Revolver. Expanding beyond the lever-action rifles and shotguns so synonymous with the Henry name, the Henry Big Boy Revolver is a historic release that will appeal even to collectors, as a rare opportunity to own the first bonafide handgun made by the long gun manufacturer. It also makes the perfect sidekick … SpletJournalTOCs is the largest, free collection of scholarly journal Tables of Contents (TOCs): 27,720 journals including 12,415 selected Open Access journals and 11,260 Hybrid … Subjects A-Z - JournalTOCs Publishers A-Z - JournalTOCs JournalTOCs *Premium* is for libraries and research information centres for which … APIs - JournalTOCs Research alerts service with the biggest collection of scholarly journal Tables of … Sign In - JournalTOCs An individual user, registered with the free service, can follow up to 20 journals. … HOME > JournalTOCs News: Recent References to JournalTOCs. 2024 - 2024. … Splet08. apr. 2024 · Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial. Roberto Diletti, Wijnand K den Dekker, Johan Bennett, Carl E Schotborgh, Rene van der Schaaf, Manel Sabaté, Raúl Moreno, patricia reyes rivera